Yukgunja-tang for Irritable Bowel Syndrome: A Protocol for a Systematic Review and Meta-Analysis
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: Irritable bowel syndrome (IBS) is a digestive disorder characterized by abdominal discomfort or pain accompanied by a change in stool condition. Owing to its complicated mechanisms, a standard treatment for IBS has not yet been established. Yukgunja-tang (YGT) is a Korean herbal medicine known in Asia to be effective in the treatment of gastrointestinal symptoms. In this study, we will conduct a systematic review of randomized controlled trials (RCTs) to assess the efficacy and safety of YGT in IBS treatment. Methods and analysis: English databases, such as Embase, Medline (via PubMed), Allied and Complementary Medicine Database, and Cochrane Central Register of Controlled Trials, will be searched for articles published up to April 2023. Additional databases, such as five Korean, one Chinese, and one Japanese database, will be included. RCTs and quasi-RCTs will also be included in the assessment of the efficacy of YGT. The overall efficacy rate will be the primary outcome, and data such as IBS quality-of-life measurements, global symptom scores, and adverse events will be the secondary outcomes. Review Manager Version 5.3 will be used for evaluation, and the risk of bias (RoB) will be evaluated using Cochrane Collaboration’s RoB tool. The Grading of Recommendations Assessment, Development, and Evaluation approach will be used to score the quality of evidence. Conclusion: This study will demonstrate the efficacy and safety of YGT for treating patients with IBS.
Abstract
Background: Irritable bowel syndrome (IBS) is a digestive disorder characterized by abdominal discomfort or pain accompanied by a change in stool condition. Owing to its complicated mechanisms, a standard treatment for IBS has not yet been established. Yukgunja-tang (YGT) is a Korean herbal medicine known in Asia to be effective in the treatment of gastrointestinal symptoms. In this study, we will conduct a systematic review of randomized controlled trials (RCTs) to assess the efficacy and safety of YGT in IBS treatment. Methods and analysis: English databases, such as Embase, Medline (via PubMed), Allied and Complementary Medicine Database, and Cochrane Central Register of Controlled Trials, will be searched for articles published up to April 2023. Additional databases, such as five Korean, one Chinese, and one Japanese database, will be included. RCTs and quasi-RCTs will also be included in the assessment of the efficacy of YGT. The overall efficacy rate will be the primary outcome, and data such as IBS quality-of-life measurements, global symptom scores, and adverse events will be the secondary outcomes. Review Manager Version 5.3 will be used for evaluation, and the risk of bias (RoB) will be evaluated using Cochrane Collaboration’s RoB tool. The Grading of Recommendations Assessment, Development, and Evaluation approach will be used to score the quality of evidence. Conclusion: This study will demonstrate the efficacy and safety of YGT for treating patients with IBS.
참고문헌 (22)
- Drossman DA, "Functional gastrointestinal disorders : history, pathophysiology, clinical features, and Rome IV", Gastroenterology, 150(6), pp.1262~1279 (2016)
- Ford AC, "Irritable bowel syndrome", The Lancet, 396(10263), pp.1675~1688 (2020)
- Oka P, "Global prevalence of irritable bowel syndrome according to Rome III or IV criteria : a systematic review and meta-analysis", Lancet Gastroenterol Hepatol, 5(10), pp.908~917 (2020)
- Muscatello MR, "Personality traits and emotional patterns in irritable bowel syndrome", World J Gastroenterol, 22(28), pp.6402~6415 (2016)
- Trinkley KE, "Treatment of irritable bowel syndrome", J Clin Pharm Ther, 36(3), pp.275~282 (2011)
- Ford AC, "American college of gastroenterology monograph on management of irritable bowel syndrome", Am J Gastroenterol, 113(suppl 2), pp.1~18 (2018)
- Ko SJ, "Effect of Korean herbal medicine combined with a probiotic mixture on diarrheadominant irritable bowel syndrome : a double-blind, randomized, placebo-controlled trial", Evid Based Complement Alternat Med, 2013, pp.824605~ (2013)
- Sujuki H, "Randomized clinical trial : Rikkunshito in the treatment of functional dyspepsia-a multicenter, double-blind, randomized, placebo-controlled study", Neurogastroenterol Motil, 26(7), pp.950~961 (2014)
- Wu Q, "The Golden Book of the Medical Order", pp.107~108 (1971), Great China Book Company
- Ko SJ, "An Herbal Medicine, Yukgunja-Tang is more Effective in a Type of Functional Dyspepsia Categorized by Facial Shape Diagnosis : A Placebo-Controlled, Double-Blind, Randomized Trial", Evid Based Complement Alternat Med, 2018, pp.8546357~ (2018)
- Drossman DA, "Rome IV-functional GI disorders : disorders of gut-brain interaction", Gastroenterology, 150(6), pp.1257~1261 (2016)
- Lacy BE, "Rome criteria and a diagnostic approach to irritable bowel syndrome", J Clin Med, 6(11), pp.99~ (2017)
- Li B, "Efficacy and safety of probiotics in irritable bowel syndrome : A systematic review and meta-analysis", Front Pharmacol, 11, pp.332~ (2020)
- Shih YS, "The effect of Xiang-Sha-Liu-Jun-Zi tang(XSLJZT)on irritable bowel syndrome : A randomized, double-blind, placebocontrolled trial", J Ethnopharmacol, 238, pp.111889~ (2019)
- Cheng CW, "CONSORT extension for Chinese herbal medicine formulas 2017 : Recommendations, explanation, and elaboration", Ann Intern Med, 167(2), pp.112~121 (2017)
- Higgins JP, "The cochrane collaboration's tool for assessing risk of bias in randomised trials", BMJ, 343, pp.d5928~ (2011)
- "GRADE Handbook" (2013)[URL]
- Sperber AD, "The global prevalence of IBS in adults remains elusive due to the heterogeneity of studies : a Rome Foundation working team literature review", Gut, 66(6), pp.1075~1082 (2017)
- Wang Y, "Efficacy of Tong-Xie-Yao-Fang granule and its impact on whole transcriptome profiling in diarrhea-predominant irritable bowel syndrome patients : study protocol for a randomized controlled trial", Trials, 21(1), pp.908~ (2020)
- Xu JP, "Effect of Xiangsha Liu-Jun-Zi-Tang Decoction on Irritable Bowel Syndrome", Journal of health for all, 02, pp.141~ (2018)
- Gou YC, "Clinical Observation on the treatment of Diarrhea-type Irritable Bowel Syndrome with Si-ni-san plus Xiangsha Liu-Jun-Zi-Tang Decoction in Liver Depression and Spleen Deficiency syndrome", Journal of traditional Chinese internal medicine, 5, pp.56~ (2013)
- Xiao Y, "Chinese herbal medicine liu jun zi tang and Xiang sha liu jun zi tang for functional dyspepsia : meta-analysis of randomized controlled trials", Evid Based Complement Altern Med, 2012, pp.936459~ (2012)